A Case Of Recurrent Helicobacter cinaedi Prosthetic Joint Infection In An HIV-Infected Man

Kedra, Joanna; Zeller, Valérie; Heym, Béate; Lehours, Philippe; Meyssonnier, Vanina; Lariven, Sylvie; Bruhl-Bénéjat, Lucie; Marmor, Simon; Ziza, Jean-Marc

doi:10.7150/jbji.28375

Cited by 5 publications

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Data on association between non- H. pylori Helicobacter species and extraintestinal diseases come from studies on extrahepatic cholangiocarcinoma,476 477 Parkinson’s disease,478 colorectal cancer479 and many other clinical entities, but solid associative evidence is lacking. Few case reports showed that H. cinaedi infections occur more often in immunocompromised patients 480–482. In addition, cases of bacteraemia of non- H. pylori Helicobacter species have been reported 483 484.…”

Section: Wg 5: Helicobacter Pylori and The Gut Microbiotamentioning

confidence: 99%

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Malfertheiner

Mégraud

Rokkas

et al. 2022

Gut

700

842

View full text Add to dashboard Cite

Helicobacter pyloriInfection is formally recognised as an infectious disease, an entity that is now included in the International Classification of Diseases 11th Revision. This in principle leads to the recommendation that all infected patients should receive treatment. In the context of the wide clinical spectrum associated with Helicobacter pylori gastritis, specific issues persist and require regular updates for optimised management.The identification of distinct clinical scenarios, proper testing and adoption of effective strategies for prevention of gastric cancer and other complications are addressed. H. pylori treatment is challenged by the continuously rising antibiotic resistance and demands for susceptibility testing with consideration of novel molecular technologies and careful selection of first line and rescue therapies. The role of H. pylori and antibiotic therapies and their impact on the gut microbiota are also considered.Progress made in the management of H. pylori infection is covered in the present sixth edition of the Maastricht/Florence 2021 Consensus Report, key aspects related to the clinical role of H. pylori infection were re-evaluated and updated. Forty-one experts from 29 countries representing a global community, examined the new data related to H. pylori infection in five working groups: (1) indications/associations, (2) diagnosis, (3) treatment, (4) prevention/gastric cancer and (5) H. pylori and the gut microbiota. The results of the individual working groups were presented for a final consensus voting that included all participants. Recommendations are provided on the basis of the best available evidence and relevance to the management of H. pylori infection in various clinical fields.

show abstract

Section: Wg 5: Helicobacter Pylori and The Gut Microbiotamentioning

confidence: 99%

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Malfertheiner

Mégraud

Rokkas

et al. 2022

Gut

700

842

View full text Add to dashboard Cite

show abstract

“…Indeed, the clinical courses and outcomes, such as complications and need for surgical treatments, in-hospital days, and mortality, were not aggravated in the present study. On the contrary, immunocompromised patients, especially those with recent chemotherapy, were likely admitted at the first visit to the ED in the present study, and previous studies also pointed out that those patients are at risk for recurrence [8,9,[22][23][24][25][26][27].…”

Section: Discussionmentioning

confidence: 51%

Helicobacter cinaedi Infections in Emergency Departments: A Descriptive Study

Izuta,

Matsuoka,

Hasuike

et al. 2023

Cureus

View full text Add to dashboard Cite

Aim: Helicobacter cinaedi , a Gram-negative spiral bacterium, is a rare cause of bacteremia in humans. Unfortunately, little is known about H. cinaedi infections in emergency departments (EDs). We aimed to describe the clinical features of H. cinaedi infections in the ED. Methods: We conducted a descriptive study at the ED of Kobe City General Hospital (KCGH) in Japan between November 2011 and December 2020. We included all ED patients with H. cinaedi infections. We retrospectively obtained the patient data from electronic medical records and described the patient characteristics, clinical course, and management of H. cinaedi infections. Results: A total of 22 patients in the ED were diagnosed with H. cinaedi infections, and all of them were detected through blood cultures. The chief complaints were vague: fever (18/22, 81.8%), chills (10/22, 45.5%), and localized pain or tenderness (8/22, 36.4%). Patients with complicated cases were also reported in the ED; three patients had vertebral osteomyelitis, two had infected aortic aneurysms, and another two had infected cysts (renal cyst and pancreatic cyst with concomitant empyema). Tetracycline (minocycline) was primarily prescribed and administered intravenously in five of 15 (33.3%) and orally in nine of 20 (45.0%) patients. Only one (4.5%) patient required surgical interventions. None of the patients died in the hospital. Conclusions: We reported the clinical features of H. cinaedi infections in the ED. Although some patients developed complicated infections, the prognosis was not poor under appropriate treatment, and most of them were successfully treated with antibiotics, primarily tetracycline.

show abstract

EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential

Ochoa

Collado

2021

Critical Reviews in Microbiology

View full text Add to dashboard Cite

A Case Of Recurrent Helicobacter cinaedi Prosthetic Joint Infection In An HIV-Infected Man

Cited by 5 publications

References 18 publications

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Management ofHelicobacter pyloriinfection: the Maastricht VI/Florence consensus report

Helicobacter cinaedi Infections in Emergency Departments: A Descriptive Study

EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential

Contact Info

Product

Resources

About